Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1874909생성일: 2026년 10월 26일
Dichloromethane → 4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide
https://huagongshe.com/reaction/1874909
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Dichloromethane | HCID 6344 | — |
| 반응물 | N-Methyl-N-nitrosourea | HCID 12699 | — |
| 반응물 | Potassium Hydroxide | HCID 14797 | — |
| 반응물 | 4-chloro-N-({4-chloro-3-[(3-cyano-5-ethenylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide | HCID 68487056 | — |
| 촉매 | palladium(II) acetate | HCID 167845 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 생성물 | 4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide | HCID 68487607 | — |
반응 단계
To a mixture of 30% aqueous KOH (30 mL) and diethyl ether (30 mL) was added N-methyl-N-nitrosourea (0.264 g, 2.56 mmol) in one potion with stirring and cooling at 0° C. and the reaction mixture was maintained at this temperature for 20 min. The organic phase was isolated, dried over KOH pellets and added dropwise to a solution of 4-chloro-N-({4-chloro-3-[(3-cyano-5-ethenylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide (0.144 g, 0.256 mmol) and palladium(II) acetate (5.8 mg, 0.026 mmol) in diethyl ether (30.0 mL) with stirring and cooling at 0° C. DCM (20 mL) was added to the reaction mixture to achieve complete solution and the reaction mixture was stirred at 0° C. for 1 h at which time LC-MS indicated complete conversion to desired product. Water and a small amount of acetic acid were added to the reaction mixture and stirred vigorously at room temperature for 1 h. The organic phase was isolated, washed with saturated aqueous NaHCO3, dried over MgSO4, filtered and concentrated to dryness. The residue was purified on 40 g silica gel eluted with 20 to 60% EtOAc/hexanes to give 4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide (0.132 g, 0.230 mmol, 90% yield) as a clear oil. 1H NMR (400 MHz, DMSO-d6) δ ppm 8.79 (t, J=5.68 Hz, 1H), 8.00 (s, 1H), 7.36-7.54 (m, 2H), 7.28 (s, 1H), 7.11 (s, 1H), 7.05 (s, 1H), 5.51 (s, 2H), 4.50 (d, J=5.68 Hz, 2H), 3.40 (t, J=8.10 Hz, 2H), 1.92-2.05 (m, 1H), 0.95-1.05 (m, 2H), 0.71-0.82 (m, 4H), −0.07 (s, 9H). LC-MS (ES−) m/z 575.13, 575.05 [M−1]. LC-MS (ES+) m/z 575.11, 577.12 [M+H].
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08304419B2 |
|---|
| 출처 데이터셋 | uspto-grants-2012_11 |
|---|
| ORD ID | ord-1e3a592c0ff44c908855241d62169de0 |
|---|
| 출처 메모 | uspto-grants-2012_11 |
|---|